
Keywords: SVR، پاسخ ویروسی بالقوه; HCV, hepatitis C virus; G3, genotype 3; SVR, sustained virological response; NS5A, non-structural 5A; PI, protease inhibitorHepatitis C virus; Direct-acting antivirals; Resistance-associated variants; Genotype 3; Cirrhosis; Chronic kidney disease (CKD); S